dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Beaulieu, Marie-Eve |
dc.contributor.author | Soucek, Laura |
dc.date.accessioned | 2021-03-19T09:43:19Z |
dc.date.available | 2021-03-19T09:43:19Z |
dc.date.issued | 2019-06-20 |
dc.identifier.citation | Beaulieu ME, Soucek L. Finding MYCure. Mol Cell Oncol. 2019 Jun 20;6(5):e1618178. |
dc.identifier.issn | 2372-3556 |
dc.identifier.uri | https://hdl.handle.net/11351/5775 |
dc.description | MYC; Peptide therapeutic; Mini-protein |
dc.description.abstract | Inhibiting the nuclear protein MYC involved in the majority of human cancers has long been considered an impossible mission and several technical challenges have discouraged the development of MYC inhibitory strategies. Nevertheless, in our recent publication in Science Translational Medicine "Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy", we demonstrate for the first time the feasibility of pharmacological MYC inhibition in vitro and in vivo using an Omomyc-based mini-protein. |
dc.language.iso | eng |
dc.publisher | Taylor and Francis |
dc.relation.ispartofseries | Molecular & Cellular Oncology;6(5) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Pèptids |
dc.subject | Oncogens |
dc.subject.mesh | Peptide Fragments |
dc.subject.mesh | /administration & dosage |
dc.subject.mesh | Proto-Oncogene Proteins c-myc |
dc.title | Finding MYCure |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1080/23723556.2019.1618178 |
dc.subject.decs | fragmentos peptídicos |
dc.subject.decs | /administración & dosificación |
dc.subject.decs | proteínas protooncogénicas c-myc |
dc.relation.publishversion | https://www.tandfonline.com/doi/full/10.1080/23723556.2019.1618178 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Beaulieu ME] Peptomyc S.L., Edifici Cellex, Barcelona, Spain. [Soucek L] Peptomyc S.L., Edifici Cellex, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Departament de Bioquímica i de Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 31528695 |
dc.identifier.wos | 000485086600009 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI13%2F01705 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |